We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca and Amgen’s Asthma Therapy Fails in Late-Stage Trial
AstraZeneca and Amgen’s Asthma Therapy Fails in Late-Stage Trial
AstraZeneca (AZ) and Amgen disclosed that their investigational asthma drug tezepelumab failed to achieve its primary endpoint of reducing dependence on oral corticosteroids while keeping asthma symptoms stable.